(Utkast) Delegert kommisjonsforordning (EU) .../... av 20. juli 2026 om endring av delegert forordning (EU) 2019/2090 med hensyn til håndhevingstiltak ved manglende overholdelse av tilbakeholdelsesfristen, grenseverdiene for restmengder eller grenseverdier, og ved ulovlig behandling
Grenseverdier for restkonsentrasjoner av farmakologisk virksomme stoffer i animalske næringsmidler: endringsbestemmelser om brudd på regelverket
Utkast til delegert kommisjonsforordning sendt til Europaparlamentet og Rådet for klarering 20.7.2026
Bakgrunn
(fra kommisjonsforordningen)
(1) Commission Delegated Regulation (EU) 2019/2090 lays down specific requirements for official controls and measures for cases of non-compliance with Union rules applicable to the use of pharmacologically active substances, among others for the cases where the competent authorities are to take specific measures in relation to noncompliance with the withdrawal period, exceedance of maximum residue limits or maximum levels or illegal treatment.
(2) Since Directive 2001/82/EC of the European Parliament and of the Council was repealed by Regulation (EU) 2019/6 of the European Parliament and of the Council, it is appropriate to replace the references to Directive 2001/82/EC in Delegated Regulation (EU) 2019/2090 accordingly.
(3) Concerning actions to be taken at the slaughterhouse, Delegated Regulation (EU) 2019/2090 sets out the rules for cases where an official veterinarian performing official controls has evidence that animals have been treated with an authorised veterinary medicinal product, but the withdrawal period as defined in Article 4(34) of Regulation (EU) 2019/6 has not been respected. Since that Regulation does not provide for actions to be taken in case where the animals concerned are already slaughtered, it is appropriate to set out the rules for such cases.
(4) Furthermore, carcases, meat and meat products and offal from the animals concerned that are still on the premises of the slaughterhouse could have been incorporated into batches containing compliant products. Therefore, it is appropriate to provide for enforcement actions to be taken by the competent authority in such cases.
(5) Concerning investigations, to clarify the origin and the extent of the non-compliance concerning the withdrawal period, it is appropriate to provide that an investigation should be performed in this respect, taking into account the nature of non-compliance.
(6) Concerning the follow-up of non-compliance, in order to ensure appropriate and harmonised enforcement to protect human health, rules should be adopted on the actions to be taken where, after investigation, non-compliance with the withdrawal period has been established.
(7) In addition, since the non-compliance as regards the withdrawal period, maximum residue limits or maximum levels and illegal treatment could concern a large variety of products originating from affected animals, and also products that have been incorporated into batches containing compliant products, the enforcement actions to be taken by the competent authority should cover such cases.
(8) Rules on administrative assistance laid down in Delegated Regulation (EU) 2019/2090 in case of non-compliance with maximum residue limits or maximum levels and in case of illegal treatment should be applied also in case of non-compliance with the withdrawal period.
(9) Delegated Regulation (EU) 2019/2090 should therefore be amended accordingly,